FDA clears Moderna’s Covid-19 vaccine for emergency use

FDA autoriza la vacuna Covid-19 de Moderna para uso de emergencia

The United States accelerates the distribution of Covid vaccines.

Photo: Scott Olson / Getty Images

The Food and Drug Administration (FDA) authorized the coronavirus vaccine manufactured by Moderna for emergency use, This will allow the shipment of millions more doses throughout the country and intensified the debate about who will be authorized next to receive this vaccine against COVID-19.

The measure will make Moderna’s vaccine the second to reach the American public, after Pfizer and BioNTech, which was licensed just a week ago.

The FDA’s decision sets the stage for an accelerated distribution of more vaccines, as expert committees begin a new round of discussions weighing whether the next wave of vaccines should go to essential workers, people 65 and older, and people with conditions that increase their risk of becoming seriously ill from Covid-19.

The FDA clearance comes the day after an agency advisory committee recommended Moderna’s Covid-19 vaccine in a near unanimous vote.

The differences between Pfizer and Moderna vaccines against coronavirus and how it affects you

Why the covid-19 pandemic decreased our ability to concentrate (and 3 simple tricks to recover it)

How You Can Minimize the Risk of Covid-19 Infection During the Holidays

The United States plans to distribute approximately 5.9 million doses of the Moderna vaccine to 64 major states, territories and cities across the country next week.

See also  A 4th of July with vegetables and fruits

The FDA licensed the Moderna vaccine for people over 18 years of age. This agency authorization is not the same as full approval, which requires more data and can usually take several more months.


Leave a Comment

Your email address will not be published.